Spain, Feb. 13 -- Spain based ROCHE FARMA, S.A. has secured contract from Gerencia de Servicio Sanitarios de Fuerteventura for Various Medicinal Products - Supply of the active principle Pertuzumab and Trastuzumab. The value of the contract is worth 42197280 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....